Nchi: Ayalandi
Lugha: Kiingereza
Chanzo: HPRA (Health Products Regulatory Authority)
AMINOPHYLLINE HYDRATE
B & S Healthcare
AMINOPHYLLINE HYDRATE
225 Milligram
Tablet Prolonged Release
Product subject to prescription which may be renewed (B)
Authorised
0000-00-00
PACKAGE LEAFLET: INFORMATION FOR THE USER PHYLLOCONTIN ® CONTINUS ® 225MG PROLONGED RELEASE TABLETS (aminophylline hydrate) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. • If any of the side effects become serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. The name of your medicine is PHYLLOCONTIN ® CONTINUS ® 225mg Prolonged release tablets but it will be referred to as _Phyllocontin Continus_ tablets throughout this leaflet. IN THIS LEAFLET: 1. What _PHYLLOCONTIN CONTINUS _tablets are and what they are used for 2. Before you take _PHYLLOCONTIN CONTINUS _tablets 3. How to take _PHYLLOCONTIN CONTINUS _tablets 4. Possible side effects 5. How to store _PHYLLOCONTIN CONTINUS _tablets 6. Further information 1. WHAT _PHYLLOCONTIN CONTINUS _TABLETS ARE AND WHAT THEY ARE USED FOR These tablets are used to treat asthma, long-term breathing difficulties such as emphysema and chronic bronchitis, and are sometimes used to treat heart failure in adults. They contain the active ingredient aminophylline which belongs to a group of medicines called bronchodilators. Bronchodilators help stop you wheezing and being breathless. Aminophylline also reduces swelling in the lungs of asthma patients and relieves the feeling of ‘tightness’ in their chest. 2. BEFORE YOU TAKE _PHYLLOCONTIN CONTINUS _TABLETS DO NOT TAKE _PHYLLOCONTIN CONTINUS _TABLETS IF YOU: are allergic (hypersensitive) to theophylline, aminophylline or any of the other ingredients of the tablet Soma hati kamili
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Phyllocontin Continus 225mg Prolonged-release Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains Aminophylline Hydrate 225 mg For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated, prolonged-release tablet _Product imported from the UK:_ Pale yellow tablets with the Napp logo marked on one side and SA on the other. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the treatment and prophylaxis of bronchospasm and inflammation associated with asthma, emphysema and chronic bronchitis. Also indicated in adults for the treatment of cardiac asthma and left ventricular or congestive cardiac failure. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of Administration Oral. The tablets should be swallowed whole and not chewed or crushed. Chewing or crushing may lead to a rapid release of aminophylline with the potential for toxicity. Adults The usual daily dose is two PHYLLOCONTIN CONTINUS tablets 225 mg twice daily following an initial week of therapy on 1 tablet 12-hourly. Children: The maintenance dose is 12 mg/kg 12-hourly adjusted to the nearest 225 mg. It is recommended that half the maintenance dose be given for the first week of therapy if the patient has not previously been receiving xanthine preparations. Some children with chronic asthma require and tolerate much higher doses (13-20 mg/kg twice daily). Lower doses (based on the usual adult dose) may be required by adolescents. Phyllocontin Continus tablets 225 mg are not suitable as a starting dose for children weighing under 40 kg. Elderly As the elderly may require lower dosages, the dose should be adjusted following the response to the initial week of therapy on 1 tablet 12-hourly. Dose Titration Pat Soma hati kamili